GI CONNECT update from ASCO GI 2017: cancers of the upper GI tract
GI CONNECT update from ASCO GI 2017: cancers of the upper GI tract
Dr Thomas Winder
GI CONNECT has summarised the highlights of ASCO GI 2017 for you.Dr Thomas Winder
Medical Oncologist
University Teaching Hospital Feldkirch
Austria
Dr Thomas Winder is board certified for haematology and medical oncology. Since January 2020 he has been Head of the Department for Haematology and Oncology at the University Teaching Hospital Feldkirch, Austria. In addition, since 2017 he has been President of the Swiss Tumor Molecular Institute in Zürich Switzerland. Dr Winder’s research focuses on molecular markers to individualize medical treatment of cancer patients. He achieved his expertise in internationally renowned laboratories at University of Southern California, Norris Comprehensive Cancer Center, Los Angeles and University Hospital Zürich, Switzerland. His research activity has been honoured by several national and international awards and high impact publications.
Dr Thomas Winder has no relevant financial relationships to disclose.
|
5 min
|
2017
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
Cancers of the upper GI tract by Dr. Thomas Winder
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.